![State of the Union Address by President Donald J. Trump February 5th, 2019](https://www.murray.senate.gov/wp-content/uploads/2021/11/PressRelease_GenPhoto10-scaled.jpg)
![State of the Union Address by President Donald J. Trump February 5th, 2019](https://www.murray.senate.gov/wp-content/uploads/2021/11/PressRelease_GenPhoto10-scaled.jpg)
![State of the Union Address by President Donald J. Trump February 5th, 2019](https://www.murray.senate.gov/wp-content/uploads/2021/11/PressRelease_GenPhoto10-scaled.jpg)
Murray and Clinton Call for GAO Investigation into FDA Outsourcing of Public Comment
Review on Plan B
July 6, 2006
(Washington, D.C.) – Senators Hillary Rodham Clinton (NY) and Patty Murray (WA) are calling for the Government Accountability Office (GAO) to investigate yet another troubling
![State of the Union Address by President Donald J. Trump February 5th, 2019](https://www.murray.senate.gov/wp-content/uploads/2021/11/PressRelease_GenPhoto10-scaled.jpg)
Statement of Sen. Patty Murray on the Proposed Washington State Pharmacy Regulation Change
June 5, 2006
“I am deeply troubled and disappointed by the proposed regulation by the Washington State Board of Pharmacy. This proposal would directly undermine Washington State’s proud
![State of the Union Address by President Donald J. Trump February 5th, 2019](https://www.murray.senate.gov/wp-content/uploads/2021/11/PressRelease_GenPhoto10-scaled.jpg)
Statement of Senators Patty Murray and Hillary Rodham Clinton on Plan B Revelations
May 25, 2006
(Washington, D.C.) – U.S. Senators Patty Murray (WA) and Hillary Rodham Clinton (NY) today issued the following statement on depositions released in a suit against
![State of the Union Address by President Donald J. Trump February 5th, 2019](https://www.murray.senate.gov/wp-content/uploads/2021/11/PressRelease_GenPhoto10-scaled.jpg)
End the delays in naming FDA commissioner
April 13, 2006
But Sens. Hillary Clinton, D-N.Y., and Patty Murray, D-Wash., are blocking the nomination until the FDA announces its decision on over-the-counter sales of the controversial